<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8">
  <meta http-equiv="X-UA-Compatible" content="IE=edge">
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <link rel="shortcut icon" href="../images/favicon.png" type="image/x-icon">
  <title>Carcinoma of the Prostate</title>
  <link href="https://cdn.jsdelivr.net/npm/remixicon@2.5.0/fonts/remixicon.css" rel="stylesheet">
  <link rel="stylesheet" href="../style.css">
  <link rel="stylesheet" href="../notes.css">

</head>
<body>
  <input type="checkbox" id="main-navigation-toggle" class="btn btn--close" title="Toggle main navigation" />
  <label for="main-navigation-toggle">
    <span></span>
  </label>
  
  <a href="../index.html">
   <div class="home-navigation">
      mtr<span class="logo-dot">.</span>
    </div>
  </a>


    <nav id="main-navigation" class="nav-main">
    <ul class="menu">
      <li class="menu__item">
        <a class="menu__link" href="../index.html">Home</a>
      </li>

      <li class="menu__item">
        <a class="menu__link" href="../about-temp2.html">About</a>
      </li>
    </ul>
  </nav>
  
      <!-- Toggle switch for dark mode -->
      <div class="dark-mode-toggle">
        <label class="switch-toggle">
            <input type="checkbox" id="dark-mode-toggle-checkbox">
            <span class="toggle-slider"></span>
        </label>
      </div>

      <!-- Progress Bar  -->
      <div id="progress-container">
        <div id="progress-bar"></div>
    </div>
      
<!-- SIDEBAR -->
<div id="sidebar" class="sidebar">
  <button id="closeSidebarBtn" class="btn toggle-btn close-btn">Close</button>
  <ul class="sidebar-menu toggle-menu">
    <!-- Add the list of topics dynamically using JavaScript -->
  </ul>
</div>

<!-- Toggle button to open the sidebar -->
<button id="toggleSidebarBtn" class="btn toggle-btn">&#9776;</button>

<!-- END OF SIDEBAR -->

  <main class="page-container">
    <div class="contribute-cta">
      <p>Help make this betterüíú</p>
      <span><a href="../contribute.html">Contribute here</a> </span>
    </div>


  <!-- TOPIC AND IMAGE CONTAINER  -->


      <h1>Carcinoma of the Prostate</h1>


  <!-- END OF TOPIC AND IMAGE CONTAINER  -->
  


    <article class="notes">
        <a id='top'></a>
    <article>

          <!-- LEARNING OBJECTIVES CONTAINER  -->
              <div class="custom-card" id="custom-card-1">
                <div class="icon"><img src="../images/icons/light-bulb.png" alt="Icon" class="icon"></div>
                <div class="title"> 
                  <h2>What You Will Learn</h2>
                </div>
                <div class="line">
                  <p>After reading this note, you should be able to...</p>
                </div>
                <div class="content">
                  <ul>
                    <li><i>This content is not available yet.</i></li>
                </ul>
                </div>
                <div class="read-more" onclick="toggleContent('custom-card-1')">Read More üç™</div>
              </div>
            
          <!-- END OF LEARNING OBJECTIVES CONTAINER  -->
        
        
          <!-- SHOW AND HIDE OUTLINE CONTAINER  -->
            <div class="outline2">
        
              <input type="radio" name="control-2" id="show-2">
              <label for="show-2">üêµ&nbsp; &nbsp;Show Outline</label>
              <input type="radio" name="control-2" id="hide-2">
              <label for="hide-2">üôà&nbsp; &nbsp; Hide Outline</label>
              <div class="contents">
                <div class="icon-box">
                  <!-- Replace 'path/to/your/icon.png' with the actual path to your PNG icon -->
                  <img src="../images/icons/book.png" alt="Icon" class="icon">
                </div>
                <div id="tableOfContents">
                    <ol id="tocList"></ol>
                </div>
              </div>
             <div>
        
        <!-- END OF SHOW AND HIDE OUTLINE CONTAINER  -->
        
        <br>
        <br>

        
            <!-- BEGINNING OF NOTE -->
        
      <section id='header-1'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-1'>Introduction</a>
          </h2>
        </header>
        <div class='body'>
          <ul>
              <li><strong>Cancer arising from the prostate gland in males.</strong></li>
              <li>The prostate is a chestnut-shaped solid organ that measures about <strong>2.5 x 3.5 cm</strong> and weighs about <strong>18-26 grams</strong>. It lies behind the pubic symphysis, extends from the bladder neck to the urogenital diaphragm, and surrounds the prostatic urethra.</li>
              <li>The prostate is composed of <strong>20% glandular tissue</strong> and <strong>80% fibromuscular tissue</strong>. It has three zones: the peripheral, transitional, and central zones. <strong>70% of prostate cancers</strong> arise from the peripheral zone.</li>
          </ul>
          
        </div>
      </section>

      <section id='header-2'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-2'>Epidemiology and Incidence</a>
          </h2>
        </header>
        <div class='body'>
          <ul>
              <li><strong>Most commonly diagnosed malignancy</strong> affecting men beyond middle age in most developing and developed countries (an incidence of approximately <strong>200,000/year</strong>).</li>
              <li>It's rare before the age of <strong>50 years</strong>; however, the incidence increases with increasing age.</li>
              <li><strong>14% of men over 50</strong> and <strong>80% of men over 70 years</strong> of age are said to have the disease.</li>
          </ul>
          

        </div>
      </section>

      <section id='header-3'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-3'>Risk Factors</a>
          </h2>
        </header>
        <div class='body'>
          <p>Little is known about the causes of the disease; however, the following can be said to be:</p>
          <ul>
              <li><strong>Risk factors:</strong> age, family or genetic factors, race</li>
              <li><strong>Probable factors:</strong> dietary fat, hormones</li>
              <li><strong>Potential risk factors:</strong> vasectomy, sexual behavior, hypervitaminosis A, vitamin D deficiency</li>
          </ul>
          
        </div>
      </section>

      <section id='header-4'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-4'>Types</a>
          </h2>
        </header>
        <div class='body'>
          <ul>
              <li><strong>Adenocarcinoma</strong>
                  <ul>
                      <li>Constitutes about <strong>85% of cases</strong>. Multifocal.</li>
                  </ul>
              </li>
              <li><strong>Transitional cell carcinoma</strong> (<strong>1-4%</strong>)</li>
              <li><strong>Pure primary squamous cell carcinoma</strong>. Osteolytic metastasis. PSA not elevated.</li>
              <li><strong>Sarcomas</strong></li>
              <li><strong>Lymphomas</strong></li>
          </ul>
          <p>Spread of the disease is usually local, hematogenous, or lymphatic spread.</p>
          
        </div>
      </section>

      <section id='header-5'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-5'>Clinical Signs and Symptoms</a>
          </h2>
        </header>
        <div class='body'>
          <ul>
              <li><strong>Asymptomatic</strong></li>
              <li><strong>Lower urinary tract symptoms</strong></li>
              <li><strong>Hematuria</strong></li>
              <li><strong>Dysuria</strong></li>
              <li><strong>Incontinence</strong></li>
              <li><strong>Retention</strong></li>
              <li><strong>Constitutional symptoms:</strong> weight loss, lethargy, anemia, etc.</li>
              <li><strong>Signs of invasion of local structures:</strong> suprapubic pain, erectile dysfunction or impotence, rectal bleeding, tenesmus, constipation, etc.</li>
              <li><strong>Signs of metastasis:</strong> low back pain, sciatica, cough, dyspnea, pathological fractures, paraplegia, headaches, seizures, palpably enlarged lymph nodes, etc.</li>
          </ul>
          
        </div>
      </section>

      <section id='header-6'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-6'>Diagnosis and Investigations</a>
          </h2>
        </header>
        <div class='body'>
          <ul>
              <li><strong>History and complete physical exam</strong></li>
              <li><strong>Digital Rectal Exam</strong></li>
              <li><strong>Estimation of PSA</strong></li>
              <li><strong>Imaging:</strong>
                  <ul>
                      <li>Transrectal ultrasonography and USS guided biopsy</li>
                      <li>Abdominopelvic USS</li>
                      <li>Bone scan or radiography</li>
                      <li>CXR</li>
                      <li>CT/MRI</li>
                      <li>IVU</li>
                  </ul>
              </li>
              <li><strong>Histological grading using Gleason combined grading system:</strong>
                  <p>It's based on the glandular pattern of the tumor. The histologic specimens are graded from <strong>1 to 5</strong>. The score is calculated from the grade by adding the two most frequent grades found in the specimen.</p>
              </li>
              <li><strong>Others:</strong> FBC, E/U/Cr., LFT</li>
          </ul>
          

                      <!-- image here -->
                      <div class="image-container">
                        <img src="../figures/carcinoma-of-the-prostate.jpg" alt="" onclick="openModal(this)">
                        <div class="caption">TNM Staging</div>
                      </div>
                      
                      <div id="myModal" class="modal">
                        <span class="close" onclick="closeModal()">&times;</span>
                        <img class="modal-content" id="modalImage">
                        <div id="caption" class="caption">TNM Staging</div>
                      </div>

        </div>
      </section>

      <section id='header-7'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-7'> Treatment</a>
          </h2>
        </header>
        <div class='body'>
          <p>Treatment depends on the staging and grade of the disease as well as overall life expectancy and the personal decision of the patient. Options include:</p>
          <ul>
              <li><strong>Watchful waiting:</strong> for elderly patients, those with short life expectancy, and those with low grade, low score cancers. They have regular PSAs and will only receive treatment if progression is suspected.</li>
              <li><strong>Endocrine treatment:</strong> for progressing disease, locally advanced disease, and metastatic disease.
                  <ul>
                      <li><strong>Antiandrogens</strong> e.g., Bicalutamide</li>
                      <li><strong>LHRH agonists treatment</strong> e.g., Zoladex</li>
                      <li><strong>Bilateral orchidectomy</strong></li>
                      <li><strong>Diethylstilbestrol</strong></li>
                  </ul>
              </li>
          </ul>
          

          <ul>
            <li><strong>Radiotherapy:</strong> for localized disease in patients with a life expectancy of over <strong>10 years</strong>. Also used to manage pain in palliative therapy.</li>
            <li><strong>Transurethral resection of the prostate (TURP):</strong> for low-grade, low-score cancers with significant bladder outflow obstruction.</li>
            <li><strong>Radical prostatectomy:</strong> for localized disease in patients with a life expectancy of over <strong>10 years</strong>. A pelvic lymph node biopsy is initially done to exclude metastasis.</li>
            <li><strong>Chemotherapy:</strong> e.g., taxane, 5FU, for hormone-resistant cancers.</li>
            <li><strong>Palliative care:</strong> terminal care for those with hormone-resistant cancer.</li>
        </ul>
        <p>Treatment combination depends on the stage or advancement of the disease.</p>
        
        </div>
      </section>

      <section id='header-8'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-8'>Complications </a>
          </h2>
        </header>
        <div class='body'>
          <ul>
              <li><strong>Retention of urine</strong></li>
              <li><strong>Infection</strong></li>
              <li><strong>Stone formation</strong></li>
              <li><strong>Hydroureter, hydronephrosis, renal failure</strong></li>
              <li><strong>Uremia</strong></li>
              <li><strong>Complications of surgery:</strong> erectile dysfunction, incontinence of urine, urethral stricture, bleeding, etc.</li>
          </ul>
          
        </div>
      </section>

      <section id='header-9'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-9'>Prevention </a>
          </h2>
        </header>
        <div class='body'>
          <ul>
              <li><strong>Screening strategies:</strong> DRE, PSA</li>
              <li><strong>Avoidance of known risk factors</strong></li>
              <li><strong>Chemoprevention:</strong> finasteride</li>
          </ul>
          
        </div>
      </section>

      <section id='header-10'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-10'> Prognosis</a>
          </h2>
        </header>
        <div class='body'>
          <ul>
              <li><strong>Prognosis</strong> depends largely on the stage at presentation. Those with localized tumors at presentation can be treated radically and have a normal life expectancy.</li>
              <li>Those with advanced or metastatic disease at presentation have a median <strong>3-year survival</strong>.</li>
              <li>However, some with noncurable hormone-resistant cancers can live many years, and a large number die from causes other than prostate cancer. Only a few over <strong>20%</strong> die from the cancer.</li>
          </ul>
          
        </div>
      </section>

      <section id='header-11'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-11'> Conclusion</a>
          </h2>
        </header>
        <div class='body'>
          <p>The future prospect of prostate cancer includes early diagnosis, better staging, and chemoprevention. Public awareness amongst the masses as well as detection of people at risk with institution of chemoprevention will relieve or address some of the disease burden.</p>
          
        </div>
      </section>

      <section id='header-12'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-12'> </a>
          </h2>
        </header>
        <div class='body'>
           <p></p>
        </div>
      </section>





      <hr style="margin: 3rem 0;">

      <!-- PRACTICE QUESTIONS CONTAINER -->

      <div class="custom-card" id="custom-card-2">
        <div class="icon"><img src="../images/icons/practice-questions.png" alt="Icon" class="icon"></div>
        <div class="title"> 
          <h2>Practice Questions</h2>
        </div>
        <div class="line">
          <p>Check how well you grasp the concepts by answering the following questions...</p>
        </div>
        <div class="content">
          <ol>
            <li><i>This content is not available yet.</i></li>
          </ol>
        </div>
        <div class="read-more" onclick="toggleContent('custom-card-2')">Read More üç™</div>
      </div>

      <!-- END OF PRACTICE QUESTIONS CONTAINER -->


      <!-- CONTACT- COMMENT AND CONTRIBUTORS CONTAINER -->
      <div class="contact">
        <div class="comment-container">
          <div class="comment-icon">
            <!-- Add your icon image here -->
            <img src="../images/icons/comment.png" alt="Comment Icon">
          </div>
          <div class="comment-text">
            <!-- Add your text here -->
            <p>Send your comments, corrections, explanations/clarifications and requests/suggestions </p>
          </div>
          <a href="https://chat.whatsapp.com/FtDdb6uEFYzBCnTnMgm2Z1" class="comment-button">
            here
            <img src="../images/icons/whatsapp.png" alt="Image Icon">
          </a>
        </div>
      </div>

       

            <!-- END OF CONTACT- COMMENT AND CONTRIBUTORS CONTAINER -->
    </article>
   </article>
   <div style="height: 300px;"></div>
  </main>

  <footer>
    <div class="footer-container">
        <div>
          <p id="popup-trigger">disclaimer</p>

          <!-- The pop-up dive content -->
          <div id="popup" class="popup">
            <p>The contents on this ‚Äòwebsite‚Äô are for educational purposes only. The creators and operators of this website make no warranties, express or implied, regarding the accuracy, currency, or completeness of the information provided on the website. They shall not be held responsible for any errors or omissions, or for any actions taken based on the information provided on this website.</p>
            <button class="popup-close" onclick="closePopup()">Close</button>
          </div>    
          <p><a href="../about-temp2.html">about</a> </p>   
          <p><a href="../contribute.html">contribute</a> </p>
          <p><a href="https://chat.whatsapp.com/FtDdb6uEFYzBCnTnMgm2Z1">say hiüëã</a> </p>
        </div>

        <div class="footer-beta">
          <p>thisisatestversion</p>
        </div>
    </div>
  </footer>
<!------------  SCROLL UP ----------->
<a href="#" class="scrollup" id="scroll-up"> 
  <i class="ri-arrow-up-fill scrollup__icon"></i>
</a>
<script src="../main.js"></script>
<script src="../modal.js"></script>
<script src="../notes-sidebar.js"></script>
</body>
</html>
 
